<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39364240</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>The role of <i>Helicobacter pylori</i> in augmenting the severity of SARS-CoV-2 related gastrointestinal symptoms: An insight from molecular mechanism of co-infection.</ArticleTitle><Pagination><StartPage>e37585</StartPage><MedlinePgn>e37585</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e37585</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e37585</ELocationID><Abstract><AbstractText>Coinfection of pathogenic bacteria and viruses is associated with multiple diseases. During the COVID-19 pandemic, the co-infection of other pathogens with SARS-CoV-2 was one of the important determinants of the severity. Although primarily a respiratory virus gastric manifestation of the SARS-CoV-2 infection was widely reported. This study highlights the possible consequences of SARS-CoV-2 -<i>Helicobacter pylori</i> coinfection in the gastrointestinal cells. We utilized the transfection and infection model for SARS-CoV-2 spike Delta (δ) and <i>H. pylori</i> respectively in colon carcinoma cell line HT-29 to develop the coinfection model to study inflammation, mitochondrial function, and cell death. The results demonstrate increased transcript levels of inflammatory markers like TLR2 (p &lt; 0.01), IL10 (p &lt; 0.05), TNFα (p &lt; 0.05) and CXCL1 (p &lt; 0.05) in pre-<i>H. pylori</i> infected cells as compared to the control. The protein levels of the β-Catenin (p &lt; 0.01) and c-Myc (p &lt; 0.01) were also significantly elevated in pre-<i>H. pylori</i> infected group in case of co-infection. Further investigation of apoptotic and necrotic markers (Caspase-3, Caspase-8, and RIP-1) reveals a necroptotic cell death in the coinfected cells. The infection and coinfection also damage the mitochondria in HT-29 cells, further implicating mitochondrial dysfunction in the necrotic cell death process. Our study also highlights the detrimental effect of pre-<i>H. pylori</i> exposure in the coinfection model compared to post-exposure and lone infection of <i>H. pylori</i> and SARS-CoV-2. This knowledge could aid in developing targeted interventions and therapeutic strategies to mitigate the severity of COVID-19 and improve patient outcomes.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Akrati</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infection Bioengineering Group, Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baral</LastName><ForeName>Budhadev</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Infection Bioengineering Group, Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saini</LastName><ForeName>Vaishali</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Infection Bioengineering Group, Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandpal</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infection Bioengineering Group, Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Amit Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Central Ayurveda Research Institute, Kolkata, 4-CN Block, Sector -V, Bidhannagar, Kolkata, 700 091, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parmar</LastName><ForeName>Hamendra Singh</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>School of Biotechnology, Devi Ahilya Vishwavidyalaya, Takshashila Campus, Indore, Madhya Pradesh, 452001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meena</LastName><ForeName>Ajay Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Regional Ayurveda Research Institute, Amkhoh, Gwalior, Madhya Pradesh, 474001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra Jha</LastName><ForeName>Hem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Infection Bioengineering Group, Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Rural Development and Technology, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Co-infection</Keyword><Keyword MajorTopicYN="N">Gastrointestine</Keyword><Keyword MajorTopicYN="N">Helicobacter pylori</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Necroptosis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39364240</ArticleId><ArticleId IdType="pmc">PMC11447314</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e37585</ArticleId><ArticleId IdType="pii">S2405-8440(24)13616-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J. Neuroimmune Pharmacol. 2020;15:359–386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373339</ArticleId><ArticleId IdType="pubmed">32696264</ArticleId></ArticleIdList></Reference><Reference><Citation>Losier A., Gupta G., Caldararo M., Dela Cruz C.S. The impact of coronavirus disease 2019 on viral, bacterial, and fungal respiratory infections. Clin. Chest Med. 2023;44:407–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9968485</ArticleId><ArticleId IdType="pubmed">37085229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehr A.R., Perlman S.  In: Coronaviruses [Internet] Maier H.J., Bickerton E., Britton P., editors. Springer New York; New York, NY: 2015. Coronaviruses: an overview of their replication and pathogenesis; pp. 1–23.http://link.springer.com/10.1007/978-1-4939-2438-7_1 [cited 2024 Feb 9]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2438-7_1</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva R.A., Rouillé Y., Dubuisson J.  International Review of Cytology. Elsevier; 2005. Interactions between virus proteins and host cell membranes during the viral life cycle; pp. 171–244.https://linkinghub.elsevier.com/retrieve/pii/S0074769605450068 [Internet]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112339</ArticleId><ArticleId IdType="pubmed">16125548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., et al. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 2020;20:493–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirbhate E., Pandey J., Patel V.K., Kamal M., Jawaid T., Gorain B., et al. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention. Pharmacol. Rep. 2021;73:1539–1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236094</ArticleId><ArticleId IdType="pubmed">34176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J., Navis G.J., Gordijn S.J., et al. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 (COVID ‐19) J. Pathol. 2020;251:228–248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S., Chong J.H., Sankaranarayanan V., Harky A. COVID-19 and multiorgan response. Curr. Probl. Cardiol. 2020;45</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukharani N., Kumar J., Makheja K., Bai P., Sharma S., Subash K., et al.  Gastrointestinal manifestation of COVID-19 in hospitalized patients. Cureus. 2021 https://www.cureus.com/articles/69591-gastrointestinal-manifestation-of-covid-19-in-hospitalized-patients [Internet]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8520409</ArticleId><ArticleId IdType="pubmed">34667695</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Chen L., Deng Q., Zhang G., Wu K., Ni L., et al. The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients. J. Med. Virol. 2020;92:833–840.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherne M.D., Gentry A.B., Nemudraia A., Nemudryi A., Hedges J.F., Walk H., et al. Severe acute respiratory syndrome coronavirus 2 is detected in the gastrointestinal tract of asymptomatic endoscopy patients but is unlikely to pose a significant risk to healthcare personnel. Gastro Hep Advances. 2022;1:844–852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9225937</ArticleId><ArticleId IdType="pubmed">35765598</ArticleId></ArticleIdList></Reference><Reference><Citation>Durairajan S.S.K., Singh A.K., Saravanan U.B., Namachivayam M., Radhakrishnan M., Huang J.-D., et al. Gastrointestinal manifestations of SARS-CoV-2: transmission, pathogenesis, immunomodulation, microflora dysbiosis, and clinical implications. Viruses. 2023;15:1231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10304713</ArticleId><ArticleId IdType="pubmed">37376531</ArticleId></ArticleIdList></Reference><Reference><Citation>Troisi J., Venutolo G., Pujolassos Tanyà M., Delli Carri M., Landolfi A., Fasano A. COVID-19 and the gastrointestinal tract: source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? WJG. 2021;27:1406–1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047540</ArticleId><ArticleId IdType="pubmed">33911464</ArticleId></ArticleIdList></Reference><Reference><Citation>Abulsoud A.I., El-Husseiny H.M., El-Husseiny A.A., El-Mahdy H.A., Ismail A., Elkhawaga S.Y., et al. Mutations in SARS-CoV-2: insights on structure, variants, vaccines, and biomedical interventions. Biomed. Pharmacother. 2023;157</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637516</ArticleId><ArticleId IdType="pubmed">36370519</ArticleId></ArticleIdList></Reference><Reference><Citation>Almehdi A.M., Khoder G., Alchakee A.S., Alsayyid A.T., Sarg N.H., Soliman S.S.M. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection. 2021;49:855–876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326314</ArticleId><ArticleId IdType="pubmed">34339040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrkalska S.D., Martínez-López A., Arroyo A.B., Martínez-Morcillo F.J., Candel S., García-Moreno D., et al. Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern. Sci. Adv. 2022;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9481140</ArticleId><ArticleId IdType="pubmed">36112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Slabakova Y., Gerasoudis S., Miteva D., Peshevska-Sekulovska M., Batselova H., Snegarova V., et al. SARS-CoV-2 variant-specific gastrointestinal symptoms of COVID-19: 2023 update. Gastroenterol. Insights. 2023;14:431–445.</Citation></Reference><Reference><Citation>Saeed N.K., Al-Khawaja S., Alsalman J., Almusawi S., Albalooshi N.A., Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. WJV. 2021;10:168–181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316874</ArticleId><ArticleId IdType="pubmed">34367932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashouri M., Nehzat Norozi Tehrani S., Karuppasamy Govindasamy, Zouhal H. Effect of Covid-19 on the lifestyles of vaccinated and unvaccinated elite athletes. A Cross-Country Analysis. HN. 2023;1:1–6.</Citation></Reference><Reference><Citation>Rassolnia A., Nobari H. The impact of socio-economic status and physical activity on psychological well-being and sleep quality among college students during the COVID-19 pandemic. Int J Sport Stud Health. 2024;7:1–12.</Citation></Reference><Reference><Citation>Bashir S.K., Khan M.B. In: Wu J., editor. vol. 2023. 2023. Overview of Helicobacter pylori infection, prevalence, risk factors, and its prevention; pp. 1–9. (Advanced Gut &amp; Microbiome Research).</Citation></Reference><Reference><Citation>Keikha M., Sahebkar A., Yamaoka Y., Karbalaei M. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J. Health Popul. Nutr. 2022;41:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8722127</ArticleId><ArticleId IdType="pubmed">34980267</ArticleId></ArticleIdList></Reference><Reference><Citation>Palrasu M., Zaika E., Paulrasu K., Caspa Gokulan R., Suarez G., Que J., et al. Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis. Blanke SR. PLoS Pathog. 2022;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242521</ArticleId><ArticleId IdType="pubmed">35767594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo D., Hoare A., Soto C., Valenzuela M.A., Quest A.F. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. WJG. 2018;24:3071–3089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064966</ArticleId><ArticleId IdType="pubmed">30065554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap D., Baral B., Jakhmola S., Singh A.K., Jha H.C. In: Damania B., editor. vol. 6. 2021. Helicobacter pylori and Epstein-Barr virus coinfection stimulates aggressiveness in gastric cancer through the regulation of gankyrin. (mSphere). 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8550222</ArticleId><ArticleId IdType="pubmed">34585958</ArticleId></ArticleIdList></Reference><Reference><Citation>Abadi T., Teklu T., Wondmagegn T., Alem M., Desalegn G. CD4+ T cell count and HIV-1 viral load dynamics positively impacted by H. pylori infection in HIV-positive patients regardless of ART status in a high-burden setting. Eur. J. Med. Res. 2024;29:178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10946129</ArticleId><ArticleId IdType="pubmed">38494500</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana S.D., Nunes S., Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – role of gut microbiota dysbiosis. Ageing Res. Rev. 2020;62</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365123</ArticleId><ArticleId IdType="pubmed">32683039</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral B., Saini V., Tandon A., Singh S., Rele S., Dixit A.K., et al.  SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1. Apoptosis [Internet] 2023 https://link.springer.com/10.1007/s10495-023-01883-9 [cited 2023 Sep 24]; Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-023-01883-9</ArticleId><ArticleId IdType="pubmed">37658919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap D., Baral B., Verma T.P., Sonkar C., Chatterji D., Jain A.K., et al. Oral rinses in growth inhibition and treatment of Helicobacter pylori infection. BMC Microbiol. 2020;20:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055109</ArticleId><ArticleId IdType="pubmed">32131741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonkar C., Verma T., Chatterji D., Jain A.K., Jha H.C. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells. BMC Cancer. 2020;20:925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523314</ArticleId><ArticleId IdType="pubmed">32993565</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney N., Murmu S., Baral B., Kashyap D., Singh S., Kandpal M., et al. Unraveling the Aurora kinase A and Epstein-Barr nuclear antigen 1 axis in Epstein Barr virus associated gastric cancer. Virology. 2023;588</Citation><ArticleIdList><ArticleId IdType="pubmed">37839162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap D., Varshney N., Baral B., Kandpal M., Indari O., Jain A.K., et al. Helicobacter pylori infected gastric epithelial cells bypass cell death pathway through the oncoprotein Gankyrin. Advances in Cancer Biology - Metastasis. 2023;7</Citation></Reference><Reference><Citation>Chang W.-L., Yeh Y.-C., Sheu B.-S. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J. Biomed. Sci. 2018;25:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6131906</ArticleId><ArticleId IdType="pubmed">30205817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorouri M., Chang T., Hancks D.C. Mitochondria and viral infection: advances and emerging battlefronts. Forero A., Yount J., editors. mBio. 2022;13 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787485</ArticleId><ArticleId IdType="pubmed">35073751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia M., Ratajczak J., Bujko K., Adamiak M., Ciechanowicz A., Chumak V., et al. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner. Leukemia. 2021;35:3026–3029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219510</ArticleId><ArticleId IdType="pubmed">34163002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Gong E., Zhang B., Zheng J., Gao Z., Zhong Y., et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005;202:415–424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213088</ArticleId><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Din A.U., Mazhar M., Waseem M., Ahmad W., Bibi A., Hassan A., et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed. Pharmacother. 2021;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657099</ArticleId><ArticleId IdType="pubmed">33197765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhao M., Fu X. Gastric microbiota dysbiosis and Helicobacter pylori infection. Front. Microbiol. 2023;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10098173</ArticleId><ArticleId IdType="pubmed">37065152</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi P., Khan A., Chattopadhyay P., Mehta P., Sahni S., Sharma S., et al. Co-Infections as modulators of disease outcome: minor players or major players? Front. Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290219</ArticleId><ArticleId IdType="pubmed">34295314</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol. J. 2022;19:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Haasbach E., Lueftenegger D., Heyken W.T., Ocker M., Planz O. NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients. Front. Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759159</ArticleId><ArticleId IdType="pubmed">33362782</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J.W., Savani R.C., Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. Elife. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.M. Role of Toll-like receptors in Helicobacter pylori infection and immunity. WJGP. 2014;5:133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4133513</ArticleId><ArticleId IdType="pubmed">25133016</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral B., Kashyap D., Varshney N., Verma T.P., Jain A.K., Chatterji D., et al. Helicobacter pylori isolated from gastric juice have higher pathogenic potential than biopsy isolates. Genes &amp; Diseases. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10425799</ArticleId><ArticleId IdType="pubmed">37588213</ArticleId></ArticleIdList></Reference><Reference><Citation>Melano I., Chen H.-J., Ngwira L., Hsu P.-H., Kuo L.-L., Noriega L., et al. Wnt3a facilitates SARS-CoV-2 pseudovirus entry into cells. IJMS. 2023;25:217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10778646</ArticleId><ArticleId IdType="pubmed">38203386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S., Keshry S.S., Ghosh S., Ray A., Chattopadhyay S. Versatile β-catenin is crucial for SARS-CoV-2 infection. Das S., editor. Microbiol. Spectr. 2022;10 22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9603097</ArticleId><ArticleId IdType="pubmed">36043864</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande R., Li W., Li T., Fanning K.V., Clemens Z., Nyunoya T., et al. SARS-CoV-2 accessory protein Orf7b induces lung injury via c-Myc mediated apoptosis and ferroptosis. IJMS. 2024;25:1157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10816122</ArticleId><ArticleId IdType="pubmed">38256231</ArticleId></ArticleIdList></Reference><Reference><Citation>Elesela S., Lukacs N.W. Role of mitochondria in viral infections. Life. 2021;11:232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998235</ArticleId><ArticleId IdType="pubmed">33799853</ArticleId></ArticleIdList></Reference><Reference><Citation>V’kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19:155–170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoraka S., Samarasinghe A.E., Ghaemi A., Mohebbi S.R. Host mitochondria: more than an organelle in SARS-CoV-2 infection. Front. Cell. Infect. Microbiol. 2023;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10485703</ArticleId><ArticleId IdType="pubmed">37692170</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wu K., Zeng S., Zhao F., Fan J., Li Z., et al. Viral infection modulates mitochondrial function. IJMS. 2021;22:4260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073244</ArticleId><ArticleId IdType="pubmed">33923929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Nguyen V., Tsai J., Gao C., Tian Y., Zhang Y., et al. The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice. Mol. Metabol. 2023;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281040</ArticleId><ArticleId IdType="pubmed">37348737</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22:1577–1590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732420</ArticleId><ArticleId IdType="pubmed">18559474</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C., Ma Z., Xie J., Li W., Su L., Zhang G., et al. The role of cell death in SARS-CoV-2 infection. Signal Transduct. Targeted Ther. 2023;8:357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10509267</ArticleId><ArticleId IdType="pubmed">37726282</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.-J., Lim S.G., Hong W. Regulation of cell death during infection by the severe acute respiratory syndrome coronavirus and other coronaviruses. Cell Microbiol. 2007;9:2552–2561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162196</ArticleId><ArticleId IdType="pubmed">17714515</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007;35:495–516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117903</ArticleId><ArticleId IdType="pubmed">17562483</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>